                         SEQUENCE LISTING

<110>  Ohio State Innovation Foundation
 
<120>  RECOMBINANT EGFL7, EGFL7 ANTIBODIES, AND USES THEREOF

<130>  10336-304WO1

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  1764
<212>  DNA
<213>  Homo sapiens

<400>  1
gcaccaagct ggccctgcac ggctgcaagg gaggctcctg tggacaggcc aggcaggtgg       60

gcctcaggag gtgcctccag gcggccagtg ggcctgaggc cccagcaagg gctagggtcc      120

atctccagtc ccaggacaca gcagcggcca ccatggccac gcctgggctc cagcagcatc      180

agagcagccc ctgtggttgg cagcaaagtt cagcttggct gggcccgctg tgaggggctt      240

cgcgctacgc cctgcggtgt cccgagggct gaggtctcct catcttctcc ctagcagtgg      300

atgagcaacc caacgggggc ccggggaggg gaactggccc cgagggagag gaaccccaaa      360

gccacatctg tagccaggat gagcagtgtg aatccaggca gcccccagga ccggggaggc      420

acaggtggcc cccaccaccc ggaggagcag ctcctgcccc tgtccggggg atgactgatt      480

ctcctccgcc aggccaccca gaggagaagg ccaccccgcc tggaggcaca ggccatgagg      540

ggctctcagg aggtgctgct gatgtggctt ctggtgttgg cagtgggcgg cacagagcac      600

gcctaccggc ccggccgtag ggtgtgtgct gtccgggctc acggggaccc tgtctccgag      660

tcgttcgtgc agcgtgtgta ccagcccttc ctcaccacct gcgacgggca ccgggcctgc      720

agcacctacc gaaccatcta taggaccgcc taccgccgca gccctgggct ggcccctgcc      780

aggcctcgct acgcgtgctg ccccggctgg aagaggacca gcgggcttcc tggggcctgt      840

ggagcagcaa tatgccagcc gccatgccgg aacggaggga gctgtgtcca gcctggccgc      900

tgccgctgcc ctgcaggatg gcggggtgac acttgccagt cagatgtgga tgaatgcagt      960

gctaggaggg gcggctgtcc ccagcgctgc gtcaacaccg ccggcagtta ctggtgccag     1020

tgttgggagg ggcacagcct gtctgcagac ggtacactct gtgtgcccaa gggagggccc     1080

cccagggtgg cccccaaccc gacaggagtg gacagtgcaa tgaaggaaga agtgcagagg     1140

ctgcagtcca gggtggacct gctggaggag aagctgcagc tggtgctggc cccactgcac     1200

agcctggcct cgcaggcact ggagcatggg ctcccggacc ccggcagcct cctggtgcac     1260

tccttccagc agctcggccg catcgactcc ctgagcgagc agatttcctt cctggaggag     1320

cagctggggt cctgctcctg caagaaagac tcgtgactgc ccagcgcccc aggctggact     1380

gagcccctca cgccgccctg cagcccccat gcccctgccc aacatgctgg gggtccagaa     1440

accacctcgg ggtgactgag cggaaggcca ggcagggcct tcctcctctt cctcctcccc     1500

ttcctcggga ggctccccag accctggcat gggatgggct gggatcttct ctgtgaatcc     1560

acccctggct acccccaccc tggctacccc aacggcatcc caaggccagg tgggccctca     1620

gctgagggaa ggtacgagct ccctgctgga gcctgggacc catggcacag gccaggcagc     1680

ccggaggctg ggtggggcct cagtgggggc tgctgcctga cccccagcac aataaaaatg     1740

aaacgtgaaa aaaaaaaaaa aaaa                                            1764


<210>  2
<211>  273
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Arg Gly Ser Gln Glu Val Leu Leu Met Trp Leu Leu Val Leu Ala 
1               5                   10                  15      


Val Gly Gly Thr Glu His Ala Tyr Arg Pro Gly Arg Arg Val Cys Ala 
            20                  25                  30          


Val Arg Ala His Gly Asp Pro Val Ser Glu Ser Phe Val Gln Arg Val 
        35                  40                  45              


Tyr Gln Pro Phe Leu Thr Thr Cys Asp Gly His Arg Ala Cys Ser Thr 
    50                  55                  60                  


Tyr Arg Thr Ile Tyr Arg Thr Ala Tyr Arg Arg Ser Pro Gly Leu Ala 
65                  70                  75                  80  


Pro Ala Arg Pro Arg Tyr Ala Cys Cys Pro Gly Trp Lys Arg Thr Ser 
                85                  90                  95      


Gly Leu Pro Gly Ala Cys Gly Ala Ala Ile Cys Gln Pro Pro Cys Arg 
            100                 105                 110         


Asn Gly Gly Ser Cys Val Gln Pro Gly Arg Cys Arg Cys Pro Ala Gly 
        115                 120                 125             


Trp Arg Gly Asp Thr Cys Gln Ser Asp Val Asp Glu Cys Ser Ala Arg 
    130                 135                 140                 


Arg Gly Gly Cys Pro Gln Arg Cys Val Asn Thr Ala Gly Ser Tyr Trp 
145                 150                 155                 160 


Cys Gln Cys Trp Glu Gly His Ser Leu Ser Ala Asp Gly Thr Leu Cys 
                165                 170                 175     


Val Pro Lys Gly Gly Pro Pro Arg Val Ala Pro Asn Pro Thr Gly Val 
            180                 185                 190         


Asp Ser Ala Met Lys Glu Glu Val Gln Arg Leu Gln Ser Arg Val Asp 
        195                 200                 205             


Leu Leu Glu Glu Lys Leu Gln Leu Val Leu Ala Pro Leu His Ser Leu 
    210                 215                 220                 


Ala Ser Gln Ala Leu Glu His Gly Leu Pro Asp Pro Gly Ser Leu Leu 
225                 230                 235                 240 


Val His Ser Phe Gln Gln Leu Gly Arg Ile Asp Ser Leu Ser Glu Gln 
                245                 250                 255     


Ile Ser Phe Leu Glu Glu Gln Leu Gly Ser Cys Ser Cys Lys Lys Asp 
            260                 265                 270         


Ser 
    


<210>  3
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3

Met Arg Gly Ser Gln Glu Val Leu Leu Met Trp Leu Leu Val Leu Ala 
1               5                   10                  15      


Val Gly Gly 
            


<210>  4
<211>  78
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4

Gly Arg Arg Val Cys Ala Val Arg Ala His Gly Asp Pro Val Ser Glu 
1               5                   10                  15      


Ser Phe Val Gln Arg Val Tyr Gln Pro Phe Leu Thr Thr Cys Asp Gly 
            20                  25                  30          


His Arg Ala Cys Ser Thr Tyr Arg Thr Ile Tyr Arg Thr Ala Tyr Arg 
        35                  40                  45              


Arg Ser Pro Gly Leu Ala Pro Ala Arg Pro Arg Tyr Ala Cys Cys Pro 
    50                  55                  60                  


Gly Trp Lys Arg Thr Ser Gly Leu Pro Gly Ala Cys Gly Ala 
65                  70                  75              


<210>  5
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  5

Cys Gln Pro Pro Cys Arg Asn Gly Gly Ser Cys Val Gln Pro Gly Arg 
1               5                   10                  15      


Cys Arg Cys Pro Ala Gly Trp Arg Gly Asp Thr Cys 
            20                  25              


<210>  6
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  6

Cys Ser Ala Arg Arg Gly Gly Cys Pro Gln Arg Cys Val Asn Thr Ala 
1               5                   10                  15      


Gly Ser Tyr Trp Cys Gln Cys Trp Glu Gly His Ser Leu Ser Ala Asp 
            20                  25                  30          


Gly Thr Leu Cys 
        35      


